Clinical Trials Browser

Phase 1/2 × Lymphoma, Non-Hodgkin × camrelizumab × Clear all

NCT04337606 2020-04-07

Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin